ERYTECH receives the EnterNext Tech 40 Label admERY April 28, 2015 Newsroom ERYTECH has received the EnterNext Tech 40 Label and announces its inclusion in the Tech 40 index. You Might Also Like ERYTECH receives Orphan Drug Designation by the FDA for eryaspase in Acute Myeloid Leukemia April 2, 2014 ERYTECH to Present at Cowen & Company 39th Annual Healthcare Conference Meeting March 8, 2019 ERYTECH Provides Business Update and Reports Cash Balance at End of Q1 2020 May 6, 2020
ERYTECH receives Orphan Drug Designation by the FDA for eryaspase in Acute Myeloid Leukemia April 2, 2014
